6,678 trials
Nephrolithiasis
Primary: Global Quality of Life Score on Postoperative Day 1 — 4.4; 5.4 score on a scale
Cystitis, Interstitial · Dysmenorrhea · Migraine Disorders
Primary: Change in Participant Bladder Pain Sensitivity From Baseline. — 38.2; 37.0; 41.2; 47.9 score on a scale — p=.02
Lung Cancer
Primary: Number of Participants With High Grade (Grade 3-4 and Grade 5) Drug-Related Select Adverse Events (AEs) — 19; 15; 4; 0 Participants
Obesity
Primary: The Number of Participants in Two Treatment Groups (1.5mg Levonorgestrel and 3mg Levonorgestrel) With no Follicle Rupture at 5 Days Within One Menstrual (Treatment)…
Insomnia · Migraine
Primary: Total Sleep Time — 5.4; 5.5; 6.3; 6.1 hours — p=0.33
Schizophrenia · Schizoaffective Disorder
Primary: Change in Serum Butyrate Levels — 2.42; 2.34; 2.88; 2.40 mg/ml
Heart Diseases · Coronary Disease · Coronary Artery Disease
Primary: Changes in Platelet Function in Response to Clopidogrel — 37.4; 20.4 percentage of maximum aggregation change
Major Depressive Disorder
Primary: Change in Scores on the Massachusetts General Hospital Cognitive and Physical Functioning Questionnaire (MGH-CPFQ) — 27.5; 29; 22.6; 25 Scores on a scale
Hypoparathyroidism
Primary: Change From Baseline in Hypoparathyroidism Symptom Diary (HypoPT-SD) Symptom Subscale Score at Week 26 — -0.93; -1.46 score on a scale — p==0.003
Rabies Human
Primary: Antibody Titers — 217.39; 805.64 IU/mL
Contraception
Primary: Pharmacokinetics in the Form of Serum Etonogestrel Concentrations — 511.7; 136.6 pg/mL
Diabetes Mellitus, Type 2
Primary: Endogenous Glucose Production Measurement — 155; 121; 104; 98 mg/dl
Delayed Graft Function
Primary: Number of Days Needed to Recover From Delayed Graft Function (DGF) — 14.0; 15.0 days
Opioid Misuse and Addiction · Pain
Primary: Morphine Milligram Equivalents Taken by Participants — 46; 15; 0 morphine milligram equivalents
Posttraumatic Stress Disorder
Primary: The Clinician Administered PTSD Scale for DSM-5 (CAPS-5) Score at Week 2 — 16.6; 17.1 score on a scale